About the Authors
- Anne-Li Lind
-
Contributed equally to this work with: Anne-Li Lind, Di Wu
Affiliation Department of Surgical Sciences, Anaesthesiology and Intensive Care and Uppsala Berzelii Technology Center for Neurodiagnostics, Uppsala University, Uppsala, Sweden
- Di Wu
-
Contributed equally to this work with: Anne-Li Lind, Di Wu
Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Eva Freyhult
-
Affiliation Department of Medical Sciences, Cancer Pharmacology and Computational Medicine, Science for Life Laboratory, Bioinformatics Infrastructure for Life Sciences, Uppsala University, Uppsala, Sweden
- Constantin Bodolea
-
Affiliation Department of Anaesthesia and Intensive Care, University of Medicine and Pharmacy, Cluj, Napoca, Romania
- Titti Ekegren
-
Affiliation Department of Engineering Sciences, Uppsala University, Uppsala, Sweden
- Anders Larsson
-
Affiliation Department of Medical Sciences, Biochemical Structure and Function, Uppsala University, Uppsala, Sweden
- Mats G. Gustafsson
-
Affiliation Department of Medical Sciences, Cancer Pharmacology and Computational Medicine, Uppsala University, Uppsala, Sweden
- Lenka Katila
-
Affiliation Department of Surgical Sciences, Anaesthesiology and Intensive Care and Uppsala Berzelii Technology Center for Neurodiagnostics, Uppsala University, Uppsala, Sweden
- Jonas Bergquist
-
Affiliation Department of Chemistry-BMC, Analytical Chemistry and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Torsten Gordh
-
Affiliation Department of Surgical Sciences, Anaesthesiology and Intensive Care and Uppsala Berzelii Technology Center for Neurodiagnostics, Uppsala University, Uppsala, Sweden
- Ulf Landegren
-
Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Masood Kamali-Moghaddam
-
* E-mail: masood.kamali@igp.uu.se
Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Competing Interests
U. Landegren is a co-founder and stockholder of the Olink Bioscience that commercializes the PLA technology. The other authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: MKM TG UL ALL DW JB TE. Performed the experiments: ALL DW. Analyzed the data: EF MGG. Contributed reagents/materials/analysis tools: AL CB TG TE LK. Wrote the paper: ALL DW EF MKM UL.